FundedIQ
Biotechnology

PolyGroup: Funding, Investors & Team (Sep 2026)

Poly Group is a licensed antimicrobial innovation organization that fosters a biocompatible antimicrobial co-polymer. The organization creates Nouvex antimicrobial, an innovation that offers antimicrobial arrangements and kills microbes/infections. The antimicrobial idea of the Nouvex treated substrate is determined, empowering materials to hold its antimicrobial movement for a significant time frame. The Nouvex's low harmfulness and huge biocompatibility possibly permit Nouvex to be utilized in items like injury dressings and implantable clinical gadgets in both human and creature applications. Poly Group was laid out in 2010 and is situated in New Albany, Indiana, United States.

www.polygroupllc.net LinkedIn New Albany, United States 11-50 employees
Biotechnology Chemical Life Science Medical Device
Total raised
$1.0M
Rounds
1
Latest
Undisclosed round
Jun 2022

PolyGroup has raised $1.0M across 1 funding round on record, the most recent an undisclosed round of $1.0M announced in Jun 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

PolyGroup Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$1.0M in Jun 2022
Employees
11-50
reported band
Headquarters
New Albany, United States

Latest funding round on record: Jun 2022.

PolyGroup Funding Rounds

Date
Round
Amount
Undisclosed round
$1.0M

PolyGroup Founders and Leadership Team

Name
Role
Contact
Craig Kalmer
Founder

No contact details are on record for this team yet.

PolyGroup Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M

PolyGroup's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like PolyGroup in Biotechnology and New Albany

Companies Similar to PolyGroup

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

PolyGroup Funding FAQs

What does PolyGroup do?

Poly Group is a licensed antimicrobial innovation organization that fosters a biocompatible antimicrobial co-polymer. The organization creates Nouvex antimicrobial, an innovation that offers antimicrobial arrangements and kills microbes/infections. The antimicrobial idea of the Nouvex treated substrate is determined, empowering materials to hold its antimicrobial movement for a significant time frame. The Nouvex's low harmfulness and huge biocompatibility possibly permit Nouvex to be utilized in items like injury dressings and implantable clinical gadgets in both human and creature applications. Poly Group was laid out in 2010 and is situated in New Albany, Indiana, United States.

How much funding has PolyGroup raised?

PolyGroup has raised $1.0M across 1 round on record. The most recent is an undisclosed round of $1.0M announced in Jun 2022.

When did PolyGroup last raise funding?

PolyGroup's most recent funding round on record is an undisclosed round of $1.0M, announced in Jun 2022.

Who founded PolyGroup?

FundedIQ lists Craig Kalmer (Founder) at PolyGroup.

Where is PolyGroup headquartered?

PolyGroup is based in New Albany, Indiana, United States.

How many employees does PolyGroup have?

PolyGroup is in the 11-50 employee band.

How does PolyGroup's funding compare to other Biotechnology startups?

PolyGroup's latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's PolyGroup Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PolyGroup is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.